Trial Profile

Gamma delta T Cell Immunotherapy for Treatment of Gastric Cancer

Status: Not yet recruiting

Phase of Trial: Phase I/II

Latest Information Update: 05 Dec 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Gamma-delta T-cell immunotherapy-Beijing Doing Biomedical (Primary)
Indications Gastric cancer
Focus Therapeutic Use
Sponsors Beijing Doing Biomedical

Most Recent Events

11 Nov 2019 Planned End Date changed from 1 Apr 2019 to 1 Dec 2022.
11 Nov 2019 Planned primary completion date changed from 1 Apr 2019 to 1 Dec 2021.
11 Nov 2019 Planned initiation date changed from 1 Oct 2017 to 1 Dec 2019.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com